A number of hypotheses have been proposed to justify the anomalous expression of P-cadherin by breast cancer cells, namely, the oncofetal properties of P-cadherin protein [37], its histogenetic origin in cap cells or acquisition of a stem cell like phenotype [68, 74]. The gene discussed is CDH3; the disease is breast carcinoma.